Multiple end point procedure to evaluate risk from pesticides. by Cantelli-Forti, G et al.
Environmental Health Perspectives Supplements
Vol. 101 (Suppl. 3): 15-20 (1993)
Multiple End Point Procedure to Evaluate Risk
from Pesticides
by G. Cantelli-Forti,' M. Paolini,' and P. Hrelial
Because ofthe potential environmental impact ofpesticides and the large population potentially exposed,
the effects of chronic exposure to pesticides need to be determined. Mutagenicity studies have been used to
identifyspecificagentsaspotentialcarcinogensorotherhuman healthhazards.However,short-termtestsare
only theoretically correlated to carcinogenesis because their end points can measure only the genotoxic
potentialofchemicals,i.e,theiractivitiesasinitiatingagentsinmultistepcarcinogenesis. Theobjectiveofour
research presented here isto provide acomprehensive examination ofthe mechanism oftoxicity ofaseries of
pesticides. These are substances for which toxicity, at both the genetic and metabolic level, has not been
adequately described. Preliminary results on a broad series of compounds belonging to different biological
classes (herbicide, insecticide, fungicide) seem to indicate that pesticides are toxic but are poor initiating
agents, as shown by negative or weak positive results on different genetic end points (gene mutations, DNA
effects,andchromosome aberrations in vitro andin vivo). Immunochemical andbiochemical studies,however,
seemtoindicate thecocarcinogenic andpromotingpotential ofthese chemicals.As an example,thegenotoxic
and biochemical effects induced by Fenarimol (a fungicide) are discussed. The results reported stress the
importance of identifying chemicals that act at different levels of the multistep carcinogenesis process to
ascertain the risk associated with exposure.
Introduction
The broad use ofpesticides represents a potential risk
to humans and to the environment. A principal goal in
pesticide research and development is identifying the spe-
cificity of action of a pesticide toward the organisms it is
supposed to kill. Only the target plant, animal, insect or
fungus shouldbeaffectedbytheapplicationoftheproduct.
However, because pesticides are designed and selected for
their biological activity, toxicity to nontarget species usu-
ally remains a signiflcant potential problem (1).
i Unintended exposure to pesticides can occur during
manufacture, formulation, application, or from environ-
mental residues after application. Because each type of
exposure has its own characteristics of magnitude and
duration and may lead to different toxicity, it is important
to consider efficacy and safety simultaneously. One ofthe
factors underlying the increased concern about the health
hazards associated with the use ofpesticides is a growing
awareness ofthe hazards associated with long-term expo-
sure to some ofthese chemicals that are persistent in soil
(organochlorine and carbamate insecticides and certain
herbicides). The insidious nature of effects such as muta-
genicity and carcinogenicity has drawn the attention of
scientists and government agencies. More comprehensive
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safety testing is required before a new pesticide is regis-
tered for use, and major efforts to reexamine the safety
data available for chemicals already in use are underway
withinregulatoryagencies (2).Predictingpotentialhuman
riskfrompesticides isbased on awide arrayoftoxicologi-
cal studies, from acute toxicity to long-term effects, but
risk assessment is especially complex for chronic disease
outcomes such as cancer, as recently stressed by Legator
and Ward (3).
Carcinogenic Assessment of
Pesticides
Testing chemicals for possible carcinogenic effects
involves many approaches. The use of short-term muta-
genicitybioassays, aimed atidentifyinggenotoxic carcino-
gens at an early stage, overcomes the high costs and long
time associated with animal carcinogenicity bioassays.
Manysophisticated short-termtestsfordetermininggen-
otoxicityhave been developed, butthey areusedprimarily
for screeningforgenetictoxicity. Short-term tests cannot
completely replace long-term bioassays because the cor-
relationbetweengenotoxicityandcarcinogenicityis notas
direct as was originally hypothesized [see for example
Zeiger (4,5) and Tennant (6)].
Short-term tests mimic only a part of the phenomena
thatwould occur in vivo (7). Cancer is now known to be a
multifactorial,multistage, andmultimechanistic diseasein
whichmanyfactors arerelevant (8,9).When chemicals areCANTELLI-FORTI ET AL.
shown to be mutagenic and induce cancer in a dose-
dependentmannerinanimals,theyaregenerallyregarded
as important carcinogens because they initiate the dis-
ease, as stipulated by the somatic mutation theory. How-
ever,recentresearchhasshownthatfactorsmodifyingthe
progression ofthe disease (promoters andinhibitors) may
be considerably important as risk determinants (10,11).
Our approach to studying the potential risk from
pesticides consists of the development of a database of
toxicologicalinformation (generaltoxicology,mutagenesis,
and carcinogenesis) on pesticides. Risk assessment from
experimental studies is based on a comprehensive exam-
ination on the mechanism of toxicity at the genetic and
metabolic (biochemical) levels.Withregardtogenotoxicity
studies, particular attention is given to cytogenetic assays
because chromosome aberration endpoints canbeused as
an early warning signal for development of cancer (12).
Experimental results are further evaluated with a semi
qualitative approach using categories ofconcern (2,3).
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Preliminary results on a broad series of compounds,
belongingto differentbiological classes (herbicides, insec-
ticides, fungicides) seem to indicate that most pesticides
are toxic but are poor initiating agents, as shown by
negative or weak positive results at different genetic end
points (13,14). Biochemical and immunochemical studies
show that pesticides induce mixed-function oxidase
enzymnes (P-450IIB1) in different organs of rodents indi-
catingacotoxic, cocarcinogenic andpromotingpotentialof
these chemicals (Paolini and Cantelli-Forti, unpublished
results).
The promoting properties of cytochrome P-450IIB1
subfamily of isozymes inducers (e.g., barbiturates,
haliphatic halogenated hydrocarbons) are acknowledged.
However, it should be noted that other inducers such as
alcohols (P-450IIE1) and dioxins (P-450IA2) are pro-
moters also (15,16).
Case Study: Fenarimol
Fenarimol [2,4-dichloro-oa-(pyrimidin-5-yl)-benzhydryl
alcohol) is a fungicide with protective, curative, and erad-
icative activities. A recent report of the U.S. National
Research Council (17) stated that fungicides contribute
nearly60%ofallestimatedoncogenicriskfrompesticides.
The committee concluded that the mode of action of
fungicides makes it rather difficult to develop compounds
that do not damage genetic material (17).
The evidence in the literature for the examined
fungicides is conflicting and incomplete. In most cases,
literature data on Fenarimol consists ofsummary ofdata
without references. This introduces considerable bias into
any assessment of the available data. Fenarimol is
reported to be negative fortheinduction ofgene mutation
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FIGURE 1. Incidence ofbreak-type aberrations induced in human lym-
phocytes exposed invitroto Fenarimol inabsence(a) andpresence (b) of
S9 mix. Results are means + SD of data obtained from two different
donors.
FIGURE 2. Frequency of micronucleated bone marrow erythrocytes in
micetreatedwith differentdoses ofFenarimol. (**)p < 0.01, (*) p < 0.05
with respect to control, Chi-square test.
a
T
..IDJ1..MULTIPLE END POINT PROCEDURE TO EVALUATE PESTICIDE RISK
in bacteria and in mouse lymphoma cells at the tk locus
(18,19). No induction of unscheduled DNA synthesis was
evaluated in primary rat hepatocytes, whereas the agent
was shown to cause mitotic nondisjunction inAspergillus
nidulans (20). Fenarimol has been associated with
increased frequencies ofmicronucleiinbone marrowofmice
after two repeated doses close to the LD50 (18). This evi-
dence is contrasted by negative results for induction of
chromosome aberrations in Chinese hamster bone marrow
and in the dominant-lethal mutagenicity assayin rat (18,19).
In the study done in our laboratories, Fenarimol was
assessed for clastogenicity with two different assays,
namely, frequency of chromosome aberrations in human
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FIGURE 3. Expression of pentoxyresorufin O-dealkylase (PROD)
activity and ethoxyresorufin O-deethylase (EROD) activity in liver
microsomes from Fenarimol-intoxicated mice. (LI) Corn oil (control), (M)
treatedwith Fenarimol, 150mg/kgbodyweight, and (mII) 300mg/kgbody
weight. Results are means ± SD ofsixindependentexperiments. (**)p <
0.01 with respect to control, using Wilcoxon's rank method.
peripheral lymphocytes (21) and an assessment of the
micronuclei frequency in mouse bone marrow using the
acridine orange stainingmethod (22,23). Inparticular, the
micronucleustechnique can measureeffects onthespindle
apparatus (aneugenicity) and chromosomes [clastogeni-
city/genotoxicity (24)].
Exposure ofhumanlymphocytes invitro obtainedfrom
two different donors to different doses of Fenarimol,
rangingfrom 1 to 100 ,ug/mL both in the presence and the
absence ofamicrosomal S9fraction obtainedfrom sodium
phenobarbital- and ,B-naphthoflavone-induced ratliver, did
notinduce anysignificantincreaseinchromosome aberra-
tions(Fig.1)Otherwise, thetreatmentofmalemice(Swiss
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FIGURE 4. Expression of pentoxyresorufin O-dealkylase (PROD)
activity and ethoxyresorufin O-deethylase (EROD) activity in kidney
microsomes from Fenarimol-intoxicated mice. (LI) Corn oil (control), (A)
treatedwithFenarimol,150mg/kgbodyweight, and(HI)300mg/kgbody
weight. Results arethe means SD ofsixindependentexperiments. (**)
p < 0.01 with respect to control, using Wilcoxon's rank method.
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albino CD1 strain) with three different doses of
Fenarimol, from 75 to 300 mg/kgbodyweight, resulted in
significant increases of micronucleated erythrocytes (up
to 5-fold over the control; p < 0.01), as detected in bone
marrow smears (Fig. 2). The increases are dose related
until adepressionoferythropoiesis appearedatthehigher
dose, corresponding to the 50% of the LD50, previously
evaluated. The disagreementofresultsobtainedinthetwo
cytogenetic assays suggests thatFenarimolmayactas an
aneugen and not a clastogen. This hypothesis, supported
by the reported effect of Fenarimol on distribution of
chromosomes leading to mitotic nondisjunction in
Aspergillus nidulans (20), needs to be validated by fur-
ther experiments.
To ascertain the possible cotoxic, cocarcinogenic, and
promotingpropertiesofFenarimol,theabilitytomodulate
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specific P-450-dependent activities inthe mousewas stud-
ied. Forthispurpose,thefungicidewasadministered IPat
150 or 300 mg/kg bodyweight in male mice (Swiss albino
CD1strain),andthepurifiedmicrosomalfractionwasthen
prepared from liver, kidney, and lung (25). NADPH-
cytochrome (P-450)c-reductase activity and selected sub-
strates (as probes) of specific P-450 isoenzymes, such as
pentoxyresorufin (P-450IIB1), ethoxyresorufin (IA1), ami-
nopyrine (IIIA), and ethoxycoumarin toward unspecific
P-450 isoforms were used (25).
The dealkylation ofpentoxyresorufin was significantly
increased up to 6.9-fold at 150 mg/kg dose in liver (Fig. 3).
On the contrary, no significant changes in the P-450IA1-
dependent oxidases was observed (Fig. 3). A similar pat-
ternofenzymaticactivitywasrecordedinkidneyandlung
microsomes. An enhancement of IIBl-like activity up to
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FIGURE 5. Expression ofpentoxyresorufin 0-dealkylase (PROD) activity andethoxyresorufin 0-deethylase (EROD) activityinlungmicrosomes from
Fenarimol-intoxicated mice. (E) Corn oil (control), (1)treatedwith Fenarimol, 150mg/kgbodyweight, and(UI)300mg/kgbodyweight. Results arethe
means + SD ofsix independent experiments. (**) p < 0.01 with respect to control, using Wilcoxon's rank method.
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FIGURE 6. Expression ofNADPH-cytochrome (P-450) c-reductase and oxidative reactions in hepaticmicrosomes from Fenarimol-intoxicated mice.(El)
Corn oil (control), (3) treatedwith Fenarimol, 150mg/kgbodyweight, and(DIf) 300mg/kgbodyweight. Results arethemeans + SD ofsixindependent
experiments. (**) p < 0.01 with respect to control, using Wilcoxon's rank method.
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2.2- and 3.8-fold in kidney (Fig. 4) and 2.5- and 2.6-fold in
lung microsomes (Fig. 5) was indeed achieved at 150 and
300 mg/kg, respectively. Ethoxyresorufin O-deethylase
was not significantly affected in both organs. The
expression of IIIA P-450-isoforms and ethoxycoumarin
O-deethylase activity (mixed) was increased at 150mg/kg
dose only (Fig. 6). Finally, increase of reductase activity
supports the monooxygenase inductions.
Theinduced expression ofCyp2Bl genesinmouseafter
repeatedadministration (3days)ofFenarimolwasdemon-
stratedbyimmunochemical analysis. Usingrabbitpolyclo-
nal antibody against P-450IIB1 (anti-cyt-P-450IIB1
purified from rat liver), we obtained clear evidence of
induction ofconstitutive levels ofP-4501IB1 proteins that
corroborate enzymatic results. The Western blotting
assay, representative of a typical experiment in liver, is
shown in Figure 7.
Conclusions
A principal goal in pesticide research is to design and
develop agents with the maximum desired response and
minimum deleterious sideeffects. This selectivityproblem
has become more acute, and the search ofnewbiologically
active compounds continues with increasing emphasis on
safety. As stochastic effects such as genotoxicity and
carcinogenicity are considered amongthe most serious of
the possible adverse effects ofpesticides, comprehensive
safetytestingisrequiredfornewmolecules.Areexamina-
tion ofthesafetydataavailable foragents alreadyinuseis
of special concern in terms of health and environmental
problems.
The literature ofpesticides reveals great disparities in
the extent ofknowledge concerning specificmechanism of
action. Most data come from short-term tests for geno-
toxicity concerning the initiating potency of a pesticide.
Otherwise, little attention is given to the promoting and
cocarcinogenic potential. The induction of metabolizing
enzymes intheliverand elsewhere mayinfactresultin an
altered metabolic state after long-term exposure.
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FIGURE 7.Westernblottinganalysis ofmousemicrosomesusingpolyclo-
nal antibody against cytochrome P-450IlB1. Position ofpurified antigen
(Mr 45,000) is indicated on the left ordinate. Untreated (corn oil, lane 1),
treatedwithsodiumphenobarbital(100mg/kgbodyweightfor3consecu-
tivedays, lane2), andtreatedwith Fenarimol (150mg/kgbodyweightfor
3 consecutive days, lane 3); 25 ,ug of microsomal protein were electro-
phoresed in each lane.
The importance ofthis phenomenon has come from the
consideration that, independent ofthe possible mutagenic
(and/or teratogenic) property, a chemical inducing P-450
function can have serious toxicological and/orgenetic con-
sequencies. In addition to the increase ofoxidative, reduc-
tive, and peroxidative metabolism ofpretoxics and premu-
tagens/precarcinogens (cotoxicity and cocarcinogenicity),
and the fact that an inducer can act as promoter in the
multistep process of carcinogenesis (at least for classes
IIB1, IA2, and IIEl P-450s), P-450 induction per se can
have a role in the development of malignancy (25,26)
Indeed, the production of several oxygen-centered radi-
cals associatedwiththeenhancement ofphase-I reactions
[reviewed in Bost (27)] can determine "oxidative stress"
contributing to the carcinogenic potential, particularly of
nongenotoxic carcinogens such as many pesticides (26).
The experimental approach presented, by evaluating
the effects ofpesticides at different levels ofthe multistep
carcinogenic process (e.g., initiation and promotion) is
fundamental to achieving a more complete and accurate
evaluation of the genotoxic/carcinogenic profile of a
pesticide. The generation of data at significant biological
end points contributes to the design ofregulatory instru-
ments through which risk to humans can be minimized.
Knowledge of the genetic and biochemical damage at
various organ sites can be used in assessing the probable
risk of the chemical. An example is represented by the
semiqualitative approach using categories of concern for
both mutagenicity and carcinogenicity (2,3).
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